Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A reliable method was developed to measure Tamsulosin and Finasteride in tablets accurately.

Finasteride may be linked to more psychiatric issues than dutasteride, but a definite cause isn't proven.

The combination of propylene glycol and Tween® 80 improves finasteride gel effectiveness.

SHH protein helps nerve regeneration in hypertensive rats.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Validated method reliably measures finasteride in tablets using liquid chromatography.

Testosterone increases muscle mass regardless of DHT conversion blocking.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

The research found that nanoparticles coated with chitosan improved the skin penetration of the drug finasteride.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Finasteride niosomes were developed and found to be effective in treating hair loss, with better results than commercial minoxidil, and could be a promising topical treatment for hair loss.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Topical finasteride is well-tolerated and satisfies most users with minimal side effects.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.